Re: Grotenhuis et al. Barrett's oesophageal adenocarcinoma encompasses tumour-initiating cells that do not express common cancer stem cell markers. J Pathol 2010; 221: 379-389

Journal of Pathology

Volumn 224, Issue 1, 2011, Pages 143-145

  Ahmad, Jawad ^a   Arthur, Ken ^a   Maxwell, Perry ^b   Kennedy, Andrew ^b   Johnston, Brian T ^a   Murray, Liam ^a   McManus, Damian ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; TUMOR MARKER;

ANTIGEN EXPRESSION; BARRETT ESOPHAGUS; CANCER ADJUVANT THERAPY; CANCER STEM CELL; CELL ISOLATION; ESOPHAGEAL ADENOCARCINOMA; GLYCOSYLATION; HUMAN; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; LETTER; PRIORITY JOURNAL; TUMOR PROMOTION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL;

EID: 79953791126     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2868     Document Type: Letter

References (10)

1. Grotenhuis BA, Dinjens WN, Wijnhoven BP, et al., Barrett's oesophageal adenocarcinoma encompasses tumour-initiating cells that do not express common cancer stem cell markers. J Pathol 2010; 221: 379-389.
2. Harvey JM, Clark GM, Osborne CK, et al., Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999; 17: 1474-1481. (Pubitemid 29220854)
3. Horst D, Kriegl L, Engel J, et al., CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer 2008; 99: 1285-1289.
4. Design and Analysis of Measurement Studies [Internet]. Available from:. Last accessed: 5 October 2010.
5. Viera AJ, Garrett JM,. Understanding interobserver agreement: the kappa statistic. Fam Med 2005; 37: 360-363. (Pubitemid 40656185)
6. Jankowski J, Barr H, Wang K, et al., Diagnosis and management of Barrett's oesophagus. Br Med J 2010; 341: c4551.
7. Mizrak D, Brittan M, Alison MR,. CD133: molecule of the moment. J Pathol 2008; 214: 3-9.
8. Bidlingmaier S, Zhu X, Liu B,. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med 2008; 86: 1025-1032.
9. Elsaba TM, Martinez-Pomares L, Robins AR, et al., The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer. PLoS One 2010; 5: e10714.
10. CD133 (C24B9) Rabbit mAb [Internet]. Available from:. Last accessed: 5 October 2010.